This inventor holds 1 USPTO granted patent. Top assignees: Korea National University of Transportation, The Catholic University of Korea. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 33 
1 out of 118 Years Active: 2017
Title: Kwang Jae Cho: Innovator in Liver-Specific Nucleic Acid Delivery Systems
Introduction
Kwang Jae Cho is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of medical technology, particularly in the development of innovative delivery systems for nucleic acids targeting liver diseases. His work is characterized by a focus on enhancing the specificity and efficacy of treatments through advanced materials.
Latest Patents
Kwang Jae Cho holds a patent for a "Metal-particle-based oral-administrating liver-specific nucleic acid delivery system and method of manufacturing the same." This invention discloses a liver-specific nucleic acid delivery system that utilizes metal nanoparticles coated with a bile acid-glycol chitosan polymer. This coating provides excellent liver-tissue specificity and high absorbance through digestive canals. The system is designed to protect the nucleic acid from enzymatic decomposition within a living organism, making it a promising candidate for oral administration in liver disease treatments. He has 1 patent to his name.
Career Highlights
Throughout his career, Kwang Jae Cho has been associated with notable institutions, including the Korea National University of Transportation Industry-Academic Cooperation Foundation and The Catholic University of Korea Industry-Academic Cooperation Foundation. His work has been instrumental in bridging the gap between academic research and practical applications in the medical field.
Collaborations
Kwang Jae Cho has collaborated with esteemed colleagues such as Yong Kyu Lee and Sung Hoon Kang. These partnerships have contributed to the advancement of his research and the successful development of innovative solutions in the field of liver disease treatment.
Conclusion
Kwang Jae Cho's contributions to the field of liver-specific nucleic acid delivery systems highlight his innovative spirit and dedication to improving medical treatments. His work continues to pave the way for advancements in the treatment of liver diseases, showcasing the importance of research and collaboration in the medical technology sector.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile